Recruiting NCT03753412

NCT03753412 Recovery From ICUAW Following Severe Respiratory and Cardiac Failure

◆ AI Clinical Summary

Plain-language summary for patients

Clinical Trial Summary
NCT ID	NCT03753412
Status	Recruiting
Phase	—
Sponsor	Barts & The London NHS Trust
Condition	Intensive Care Unit Syndrome
Study Type	OBSERVATIONAL
Enrollment	100 participants
Start Date	2019-04-09
Primary Completion	2026-09-26

Trial Parameters

Condition Intensive Care Unit Syndrome

Sponsor Barts & The London NHS Trust

Study Type OBSERVATIONAL

Phase N/A

Enrollment 100

Sex ALL

Min Age 18 Years

Max Age N/A

Start Date 2019-04-09

Completion 2026-09-26

All Conditions

Intensive Care Unit Syndrome Intensive Care Neuropathy Intensive Care (ICU) Myopathy Acute Respiratory Distress Syndrome Cardiac Failure Respiratory Failure Critical Illness Myopathy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Your Age

Your Sex

Brief Summary

To observe and identify determinants of recovery from intensive care unit-acquired weakness (ICUAW) following a severe cardiorespiratory failure requiring extra-corporeal membrane oxygenation (ECMO). Additionally, to discover the effects of ICUAW on physical function and health-related quality of life (HRQoL) after critical illness. CLEVERER is a clinical observational pilot study.

Eligibility Criteria

Inclusion Criteria: * Above the age of 18 * Adults with severe cardio-respiratory failure requiring ECMO. * Adults who have had personal and professional consultees agree to enrol them in the trial. Exclusion criteria: * Previous Stroke * Neuromuscular disease * Malignancy * Underlying neuromuscular disease * paediatrics

Related Trials

NCT03753412

Recovery From ICUAW Following Severe Respiratory and Cardiac Failure

View Trial →

VIEW ON CLINICALTRIALS.GOV ↗ MORE INTENSIVE CARE UNIT SYNDROME TRIALS

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology